Lenalidomide may be an alternative treatment of recurrent erythema multiforme

1351 Views

eMediNexus 11 March 2018

Lenalidomide may be an alternative (off-label) to thalidomide for the treatment of recurrent erythema multiforme as reported in a series of three cases published online February 14, 2018 in JAMA Dermatology. Adverse events may limit the use of thalidomide as long-term treatment.

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.